Pro Share Advisors LLC Ascendis Pharma A/S Transaction History

Pro Share Advisors LLC

$36.7 Billion
Q1 2024

A detailed history of Pro Share Advisors LLC transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Pro Share Advisors LLC holds 4,025 shares of ASND stock, worth $542,409. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,025

Previous 3,664 9.85%

Holding current value

$542,409

Previous $461,000 31.89%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	BUY	$123.45 - $159.4 $44,565 - $57,543	361 Added 9.85%	4,025 $608,000
Q4 2023 Feb 14, 2024	SELL	$86.1 - $127.36 $5,768 - $8,533	-67 Reduced 1.8%	3,664 $461,000
Q3 2023 Nov 13, 2023	BUY	$86.5 - $103.97 $3,373 - $4,054	39 Added 1.06%	3,731 $349,000
Q2 2023 Aug 10, 2023	SELL	$69.96 - $97.84 $17,909 - $25,047	-256 Reduced 6.48%	3,692 $329,000
Q1 2023 May 11, 2023	SELL	$104.9 - $126.78 $70,387 - $85,069	-671 Reduced 14.53%	3,948 $423,000

Q4 2022 Feb 02, 2023	SELL	$99.42 - $131.97 $4,772 - $6,334	-48 Reduced 1.03%	4,619 $564,000
Q3 2022 Nov 04, 2022	BUY	$84.03 - $110.23 $29,158 - $38,249	347 Added 8.03%	4,667 $482,000
Q2 2022 Aug 01, 2022	SELL	$78.08 - $117.61 $110,717 - $166,770	-1,418 Reduced 24.71%	4,320 $402,000
Q1 2022 May 10, 2022	SELL	$102.18 - $135.75 $209,571 - $278,423	-2,051 Reduced 26.33%	5,738 $673,000
Q4 2021 Feb 08, 2022	SELL	$127.1 - $169.66 $430,741 - $574,977	-3,389 Reduced 30.32%	7,789 $1.05 Million
Q3 2021 Nov 12, 2021	BUY	$112.67 - $176.92 $201,679 - $316,686	1,790 Added 19.07%	11,178 $1.78 Million
Q2 2021 Aug 13, 2021	BUY	$121.62 - $145.29 $263,793 - $315,134	2,169 Added 30.05%	9,388 $1.24 Million
Q1 2021 May 14, 2021	SELL	$124.92 - $173.33 $96,813 - $134,330	-775 Reduced 9.69%	7,219 $930,000
Q4 2020 Feb 09, 2021	BUY	$151.2 - $182.76 $70,156 - $84,800	464 Added 6.16%	7,994 $1.33 Million
Q3 2020 Nov 13, 2020	BUY	$134.29 - $154.32 $20,680 - $23,765	154 Added 2.09%	7,530 $1.16 Million
Q2 2020 Aug 03, 2020	BUY	$110.87 - $156.01 $117,411 - $165,214	1,059 Added 16.76%	7,376 $1.09 Million
Q1 2020 May 15, 2020	SELL	$97.01 - $145.11 $348,750 - $521,670	-3,595 Reduced 36.27%	6,317 $711,000
Q4 2019 Feb 12, 2020	SELL	$91.45 - $139.12 $224,326 - $341,261	-2,453 Reduced 19.84%	9,912 $1.38 Million
Q3 2019 Nov 12, 2019	SELL	$95.8 - $118.9 $75,394 - $93,574	-787 Reduced 5.98%	12,365 $1.19 Million
Q2 2019 Aug 13, 2019	SELL	$107.11 - $132.09 $56,982 - $70,271	-532 Reduced 3.89%	13,152 $1.51 Million
Q1 2019 May 15, 2019	BUY	$62.15 - $129.99 $14,667 - $30,677	236 Added 1.75%	13,684 $1.61 Million
Q4 2018 Feb 14, 2019	SELL	$55.16 - $69.67 $146,504 - $185,043	-2,656 Reduced 16.49%	13,448 $843,000
Q3 2018 Nov 14, 2018	BUY	$63.77 - $76.28 $16,835 - $20,137	264 Added 1.67%	16,104 $1.14 Million
Q2 2018 Aug 13, 2018	BUY	$58.55 - $73.92 $43,912 - $55,440	750 Added 4.97%	15,840 $1.05 Million
Q1 2018 May 14, 2018	SELL	$38.98 - $68.04 $84,196 - $146,966	-2,160 Reduced 12.52%	15,090 $987,000
Q4 2017 Feb 14, 2018	BUY	$31.98 - $40.38 $551,655 - $696,555	17,250	17,250 $691,000

Others Institutions Holding ASND

# of Institutions

212

Shares Held

46.6M

Call Options Held

310K

Put Options Held

306K

View Full List

About Ascendis Pharma A/S

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $7.52B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

More about ASND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Account

Pro Share Advisors LLC Ascendis Pharma A/S Transaction History